Integra takes cranial technology to "$80 million" US sector:
This article was originally published in Clinica
Integra LifeSciences Holdings plans to start selling this month in the US its KraniOS cranial closure system for closing cranial bone flaps. The product consists of low-profile titanium implants for reduced palpability and screws designed with a head that allows for stable insertion, said the Plainsboro, New Jersey firm, which will market the system through its domestic Integra NeuroSciences sales force. The screws also have the strength to minimise stripping while maintaining a low profile.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.